What does the Polycystic Kidney Disease Gene Panel include?
It includes detailed genetic sequencing performed by Metropolis Healthcare to detect mutations associated with PKD.
How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses high-resolution NGS platforms to analyze genes responsible for kidney cyst formation from an EDTA blood sample.
Who should take this test?
Individuals with kidney cysts, early kidney dysfunction, or a family history of polycystic kidney disease may benefit.
Can this test distinguish between ADPKD and ARPKD?
Yes, the panel helps differentiate between autosomal dominant and autosomal recessive PKD by identifying specific gene mutations.
What sample is required for this test?
An EDTA blood sample is required for DNA extraction and comprehensive gene analysis.
Is this test useful for family planning and counseling?
Yes, identifying the causative mutation helps determine inheritance risks and supports genetic counseling for families.
How long does Metropolis Healthcare take to deliver results?
Results generally take a few weeks due to detailed sequencing and interpretation.
Does this test guide treatment or management?
While it does not alter treatment directly, genetic confirmation helps clinicians monitor complications, plan interventions, and guide long-term kidney care.